Glenmark Pharmaceuticals gets USFDA nod for Fingolimod capsules

"Glenmark Pharmaceuticals Inc, USA has been granted final approval by the United States Food and Drug Administration (USFDA) for Fingolimod Capsules, 0.5 mg, the generic version of Gilenya capsules, 0.5 mg, of Novartis Pharmaceuticals Corporation," the drug major said in a filing to BSE.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2YPMH9H
via IFTTT